English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1268]
News [2529]
Articles [101]
Editorials [4]
Conferences [119]
elearning [25]
New treatment with fewer side effects reduces breast density
New treatment with fewer side effects reduces breast density
Lower volume bowel preparation as effective and safe as higher volume regimen for inpatient colonoscopy
Lower volume bowel preparation as effective and safe as higher volume regimen for inpatient colonoscopy
Targeted therapy drug shows early promise against KRAS-driven lung and pancreatic cancers
Targeted therapy drug shows early promise against KRAS-driven lung and pancreatic cancers
Researchers identify promising new therapeutic target for pancreatic cancer
Researchers identify promising new therapeutic target for pancreatic cancer
AACR 2026: Early myocarditis onset after immunotherapy may predict treatment-related fatality
AACR 2026: Early myocarditis onset after immunotherapy may predict treatment-related fatality
Some cancer drugs disrupt taste by changing the cells inside taste buds, study shows
Some cancer drugs disrupt taste by changing the cells inside taste buds, study shows
AACR 2026: BCMA-directed CAR T-cell therapy may be effective against high-risk smouldering multiple myeloma
AACR 2026: BCMA-directed CAR T-cell therapy may be effective against high-risk smouldering multiple myeloma
Exercise and cancer research: Ibuprofen is another option to ease chemo-brain
Exercise and cancer research: Ibuprofen is another option to ease chemo-brain
AACR 2026: New KIR-CAR T cell therapy shows promise in multiple solid cancers
AACR 2026: New KIR-CAR T cell therapy shows promise in multiple solid cancers
AACR 2026: Phase 1 study explores toxicity reduction in combination of trastuzumab deruxtecan and olaparib in advanced HER2-expressing malignancies
AACR 2026: Phase 1 study explores toxicity reduction in combination of trastuzumab deruxtecan and olaparib in...
<12345…253>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2026 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top